HAOLAT BABALAKIN: Open Payments
NPI 1245337708 · BERKELEY LAKE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,427 in 126 payments from 18 companies in 2025. Trend: 2023 $4,065 · 2024 $3,268 · 2025 $3,427
Food & beverage: $3,427
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 14 | $653 |
| Otsuka America Pharmaceutical, Inc. | 12 | $352 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $336 |
| Alkermes, Inc. | 4 | $273 |
| Tris Pharma Inc | 7 | $248 |
| Vanda Pharmaceuticals Inc. | 8 | $242 |
| Supernus Pharmaceuticals, Inc. | 6 | $222 |
| ABBVIE INC. | 19 | $217 |
| Lundbeck LLC | 8 | $214 |
| Corium, LLC | 10 | $173 |
Products named: INVEGA SUSTENNA, REXULTI, CAPLYTA, Dyanavel XR, FANAPT, Qelbree, VRAYLAR, Azstarys.
Industry payments across GA — which companies pay providers there.
